SPI Pharmaceuticals Inc.: The Costa Mesa company...
From Times Staff and Wire Reports
SPI Pharmaceuticals Inc.: The Costa Mesa company reported first-quarter income of $3.2 million, a 12% rise over the year-ago period. Sales were $30.6 million, down from last year’s $33.7 million. The company said its performance was led by international operations, particularly in Europe, where sales were up 17%.
Tables, D11
